Title : Anthracycline Use for Early Stage Breast Cancer in the Modern Era: a Review.

Pub. Date : 2018 May 11

PMID : 29752560






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Based on current literature, for HER2-negative patients with low-risk breast cancer, anthracyclines could be spared with regimens such as cyclophosphamide, methotrexate, and fluorouracil (CMF) or docetaxel and cyclophosphamide (TC). Anthracyclines erb-b2 receptor tyrosine kinase 2 Homo sapiens
2 For the remaining patients with HER2 overexpression, while docetaxel, carboplatin, and trastuzumab (TCH) has demonstrated to improve disease-free survival (DFS), anthracycline-containing regimens should be discussed, especially for those with very high-risk breast cancer. Anthracyclines erb-b2 receptor tyrosine kinase 2 Homo sapiens